These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22055548)

  • 21. Using economic evidence to support policy decisions to fund interventions for non-communicable diseases.
    Bertram M; Banatvala N; Kulikov A; Belausteguigoitia I; Sandoval R; Hennis A; Webb D; Tarlton D
    BMJ; 2019 May; 365():l1648. PubMed ID: 31110025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The actual approaches to the economic analysis of effectiveness of functioning of multi-profile curative preventive medical institution].
    Gaĭdarov GM; Alekseeva NIu; Latysheva EA
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2010; (5):34-7. PubMed ID: 21375047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of public health interventions.
    Owen L; Morgan A; Fischer A; Ellis S; Hoy A; Kelly MP
    J Public Health (Oxf); 2012 Mar; 34(1):37-45. PubMed ID: 21933796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Criteria for the selection for the funding of actions under the "Public Health" programme].
    Cianciara D
    Przegl Epidemiol; 2005; 59(4):945-50. PubMed ID: 16729436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tension between cost-utility analysis and preventive public health.
    Hyun I
    Med Law; 2006 Sep; 25(3):483-90. PubMed ID: 17078521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood Obesity Research Demonstration project: cross-site evaluation methods.
    O'Connor DP; Lee RE; Mehta P; Thompson D; Bhargava A; Carlson C; Kao D; Layne CS; Ledoux T; O'Connor T; Rifai H; Gulley L; Hallett AM; Kudia O; Joseph S; Modelska M; Ortega D; Parker N; Stevens A;
    Child Obes; 2015 Feb; 11(1):92-103. PubMed ID: 25679060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Health economic evaluation of rehabilitation programmes in the "rehabilitation sciences" research funding programme in Germany].
    Krauth C; Hessel F; Klingelhöfer HE; Schweikert B; Hansmeier T; Wasem J
    Rehabilitation (Stuttg); 2005 Oct; 44(5):297-306. PubMed ID: 16208593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the role of economics in prioritization in public health: what do stakeholders think?
    Phillips CJ; Fordham R; Marsh K; Bertranou E; Davies S; Hale J; Kingsley M; Parke S; Porteous C; Rance J; Warm D
    Eur J Public Health; 2011 Oct; 21(5):578-84. PubMed ID: 20817687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention research and its actual application to health services.
    Holder HD
    J Behav Health Serv Res; 2001 May; 28(2):118-29. PubMed ID: 11338324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
    Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
    BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing costs and potential returns of evidence-based programs for seniors.
    Miller TR; Dickerson JB; Smith ML; Ory MG
    Eval Health Prof; 2011 Jun; 34(2):201-25. PubMed ID: 21196430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Principles of economic evaluation in intervention programmes].
    Mazur J
    Med Wieku Rozwoj; 2000; 4(4 Suppl 1):89-98. PubMed ID: 11490063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of resource allocation models in selecting clinical preventive services.
    Wang LY; Haddix AC; Teutsch SM; Caldwell B
    Am J Manag Care; 1999 Apr; 5(4):445-54. PubMed ID: 10387384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic evaluation.
    Drummond MF; Aguiar-Ibanez R; Nixon J
    Singapore Med J; 2006 Jun; 47(6):456-61; quiz 462. PubMed ID: 16752012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cost-benefit analysis framework for preventive health interventions to aid decision-making in Australian governments.
    Ananthapavan J; Moodie M; Milat A; Veerman L; Whittaker E; Carter R
    Health Res Policy Syst; 2021 Dec; 19(1):147. PubMed ID: 34923970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What every doctor should know about economics. Part 2. The benefits of economic appraisal.
    Hall J; Mooney G
    Med J Aust; 1990 Jan; 152(2):80-2. PubMed ID: 2104950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of terminology and methodology in economic analyses in otolaryngology.
    Kezirian EJ; Yueh B
    Otolaryngol Head Neck Surg; 2001 May; 124(5):496-502. PubMed ID: 11337651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.